American Foundation For Urologic Disease is categorized under Medical Research in Baltimore, MD and active since 1987.
American Foundation For Urologic Disease was established in 1987, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Medical Research business, which does work in the B2B market, and is classified as a Medical Research, under code number 541720 by the NAICS.
If you are seeking more information, feel free to contact Peter Giusti at the company’s headquarters by writing to 1000 Corporate Boulevard, Baltimore, Maryland MD 21201 or by phoning (410) 689-3990. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | American Foundation For Urologic Disease |
Contact Person: | Peter Giusti |
Address: | 1000 Corporate Boulevard, Baltimore, Maryland 21201 |
Phone Number: | (410) 689-3990 |
Annual Revenue (USD): | $500.000 to $999.999 |
Founded: | 1987 |
Location Type: | Headquarters |
Employee Number: | 1 to 4 |
Business Type: | B2B (Business to Business) |
Business Category: | Medical Research |
SIC Code: | 8733 |
NAICS Code: | 541720 |
Share This Business: |
American Foundation For Urologic Disease was started in 1987 to provide professional Medical Research under the SIC code 8733 and NAICS code 541720. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Peter Giusti for inquiries that concern American Foundation For Urologic Disease by calling the company number (410) 689-3990, as your correspondence is most welcome. Additionally, the physical location of the headquarters of American Foundation For Urologic Disease can be found at the coordinates 39.367604,-76.473769 as well as the street address 1000 Corporate Boulevard in Baltimore, Maryland 21201.
For its online presence, you may visit American Foundation For Urologic Disease’s website at and engage with its social media outlets through on Twitter and on Facebook.